Evidence map›Paper›PMID 26155506›Full record

ArticleJournal of clinical and diagnostic research : JCDR2015

Effectiveness of Insulin Glargine on Recovery of Patients with Diabetic Ketoacidosis: A Randomized Controlled Trial.

Jalil Houshyar, Amir Bahrami, Akbar Aliasgarzadeh

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Journal of clinical and diagnostic research : JCDR, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
0.7field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04567225 phase4terminatednot on this mapstarted 2020, after this paper: background citation

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

TypeinterventionalSponsorThe Cleveland ClinicRan2020 to 2021Enrolled39ConditionsDiabetic Ketoacidosis, Type 1 Diabetes, Type 2 DiabetesArmsEarly Glargine, Late Glargine, IV insulin infusion, IV fluid and electrolytes replacement
NCT06007508 phase2terminatednot on this mapstarted 2022, after this paper: background citation

Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis

TypeinterventionalSponsorHealthPartners InstituteRan2022 to 2023Enrolled8ConditionsDKAArmsInsulin Glargine
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jalil HoushyarAssistant Professor, Department of Medicine, Endocrine Section, Endocrine Research Center, Tabriz University of Medical Sciences , Iran .
Amir BahramiProfessor, Department of Medicine, Endocrine Section, Endocrine Research Center, Tabriz University of Medical Sciences , Iran .
Akbar AliasgarzadehAssociate Professor, Department of Medicine, Endocrine Section, Endocrine Research Center, Tabriz University of Medical Sciences , Iran .
Tabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic Ketoacidosis (DKA) is a major hyperglycemic emergency in diabetes mellitus (DM). The basic treatment is injection of Regular insulin (RI). This study was aimed to investigate the effects of insulin Glargine (GI) on recovery of patients with DKA. MATERIALS AND

methodsA randomized clinical trial conducted on 40 patients (twenty patients in each group) with DKA. Both groups received standard treatment for DKA. Experimental group was given 0.4U/kg of GI within three hours of initiation of IV insulin infusion.

resultsThe mean duration of acidosis correction time and recovery from DKA was 13.77±6.10 and 16.91±6.49 h in the intervention and control groups respectively (p=0.123). The mean dosage of RI until recovery from DKA was 84.8±45.6 in the intervention and 116.5±91.6 units in control groups (p=0.17). Hypokalemia occurred in three patients in intervention and four patients in control groups. In 35% of samples in intervention group and 51% in controls blood sugar was more than 10 mmol/l for 24 h after discontinuation of the insulin infusion (p=0.046). The mean duration of hospitalization was 5.1±1.88 in intervention and 5.9±2.19 d in control group (p=0.225).

conclusionAdding GI to the standard treatment of DKA reduced average time of recovery from DKA, without incurring episodes of hypoglycemia and hypokalemia. This also reduced in the time of recovery from DKA, amount of required insulin and the duration of hospitalization. It seems that the non-significant difference in the time of recovery from DKA be related to the small sample size and study design. Further studies are recommended.

Indexed as

Diabetes mellitusHyperglycemiaTreatment

Identifiers

PMID26155506
PMCPMC4484098
OpenAlexW2401970672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.